🎁 Black Friday: up to 50% off of annual plans
GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
47.76
-0.06 (-0.13%)
At close: Nov 20, 2026, 4:00 PM EST
47.66
-0.10 (-0.21%)
After-hours: Nov 20, 2026, 7:57 PM EST

GSK Statistics

Total Valuation

GSK has a market cap or net worth of $96.76 billion. The enterprise value is $123.54 billion.

Market Cap96.76B
Enterprise Value 123.54B

Important Dates

The last earnings date was Wednesday, October 28, 2026, before market open.

Earnings Date Oct 28, 2026
Ex-Dividend Date Nov 13, 2026

Share Statistics

GSK has 4.01 billion shares outstanding. The number of shares has decreased by -1.37% in one year.

Current Share Class n/a
Shares Outstanding 4.01B
Shares Change (YoY) -1.37%
Shares Change (QoQ) +0.27%
Owned by Insiders (%) 0.06%
Owned by Institutions (%) 83.84%
Float 3.89B

Valuation Ratios

The trailing PE ratio is 17.11 and the forward PE ratio is 10.08.

PE Ratio 17.11
Forward PE 10.08
PS Ratio 2.17
Forward PS 2.12
PB Ratio 3.89
P/TBV Ratio n/a
P/FCF Ratio 9.97
P/OCF Ratio 8.29
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.10, with an EV/FCF ratio of 12.73.

EV / Earnings 21.39
EV / Sales 2.77
EV / EBITDA 8.10
EV / EBIT 9.08
EV / FCF 12.73

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 1.30.

Current Ratio 0.86
Quick Ratio 0.55
Debt / Equity 1.30
Debt / EBITDA 2.03
Debt / FCF 3.26
Interest Coverage 14.37

Financial Efficiency

Return on equity (ROE) is 28.27% and return on invested capital (ROIC) is 25.65%.

Return on Equity (ROE) 28.27%
Return on Assets (ROA) 9.63%
Return on Invested Capital (ROIC) 25.65%
Return on Capital Employed (ROCE) 20.10%
Weighted Average Cost of Capital (WACC) 5.03%
Revenue Per Employee $666,241
Profits Per Employee $86,421
Employee Count66,841
Asset Turnover 0.50
Inventory Turnover 1.42

Taxes

In the past 12 months, GSK has paid $744.79 million in taxes.

Income Tax 744.79M
Effective Tax Rate 10.42%

Stock Price Statistics

The stock price has increased by +3.06% in the last 52 weeks. The beta is 0.28, so GSK's price volatility has been lower than the market average.

Beta (5Y) 0.28
52-Week Price Change +3.06%
50-Day Moving Average 49.31
200-Day Moving Average 52.25
Relative Strength Index (RSI) 38.62
Average Volume (20 Days) 3,628,422

Short Selling Information

The latest short interest is 16.15 million, so 0.81% of the outstanding shares have been sold short.

Short Interest 16.15M
Short Previous Month 14.80M
Short % of Shares Out 0.81%
Short % of Float n/a
Short Ratio (days to cover) 2.72

Income Statement

In the last 12 months, GSK had revenue of $44.53 billion and earned $5.78 billion in profits. Earnings per share was $2.79.

Revenue44.53B
Gross Profit 32.85B
Operating Income 13.60B
Pretax Income 7.15B
Net Income 5.78B
EBITDA 15.26B
EBIT 13.60B
Earnings Per Share (EPS) $2.79
Full Income Statement

Balance Sheet

The company has $3.93 billion in cash and $31.60 billion in debt, with a net cash position of -$27.67 billion or -$13.80 per share.

Cash & Cash Equivalents 3.93B
Total Debt 31.60B
Net Cash -27.67B
Net Cash Per Share -$13.80
Equity (Book Value) 24.38B
Book Value Per Share 12.42
Working Capital -3.75B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $11.66 billion and capital expenditures -$1.96 billion, giving a free cash flow of $9.71 billion.

Operating Cash Flow 11.66B
Capital Expenditures -1.96B
Depreciation & Amortization 1.63B
Net Borrowing 8.23B
Free Cash Flow 9.71B
FCF Per Share $4.84
Full Cash Flow Statement

Margins

Gross margin is 73.76%, with operating and profit margins of 30.54% and 12.97%.

Gross Margin 73.76%
Operating Margin 30.54%
Pretax Margin 16.05%
Profit Margin 12.97%
EBITDA Margin 34.26%
EBIT Margin 30.54%
FCF Margin 22.13%

Dividends & Yields

This stock pays an annual dividend of $1.80, which amounts to a dividend yield of 3.78%.

Dividend Per Share $1.80
Dividend Yield 3.78%
Dividend Growth (YoY) 7.71%
Years of Dividend Growth 2
Payout Ratio 64.67%
FCF Payout Ratio 37.26%
Buyback Yield 1.37%
Shareholder Yield 5.14%
Earnings Yield 5.84%
FCF Yield 10.03%
Dividend Details

Analyst Forecast

The average price target for GSK is $59.12, which is 23.79% higher than the current price. The consensus rating is "Hold".

Price Target $59.12
Price Target Difference 23.79%
Analyst Consensus Hold
Analyst Count 9
Revenue Growth Forecast (3Y) 3.73%
EPS Growth Forecast (3Y) 4.42%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 1:1.25.

Last Split Date Jul 19, 2022
Split Type Reverse
Split Ratio 1:1.25

Scores

GSK has an Altman Z-Score of 1.99 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.99
Piotroski F-Score 6